Indaptus Therapeutics, Inc. (INDP) Financials

$11.87

$0.56 (4.91%)
Last update: 04:00 PM EST
Day's range
$11.28
Day's range
$11.92
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201820182019201920202020202120212022202220232023202420245%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

INDP Income statement / Annual

Last year (2024), Indaptus Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Indaptus Therapeutics, Inc.'s net income was -$15.02 M. See Indaptus Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $1.28 K $1.78 K $1.40 K $852.00 $854.00 K $859.00 K $829.00 K $701.00 K $745.90 K
Gross Profit $0.00 -$1.28 K -$1.78 K -$1.40 K -$852.00 -$854.00 K -$859.00 K -$829.00 K -$701.00 K -$745.90 K
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $7.25 M $7.62 M $6.32 M $2.52 M $2.66 M $26.66 M $35.40 M $24.30 M $10.07 M $4.09 M
General & Administrative Expenses $8.11 M $8.66 M $8.59 M $5.21 M $944.25 K $542.56 K $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $100.74 K $0.00 $0.00 $0.00 $7.43 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $8.11 M $8.76 M $8.59 M $5.21 M $944.25 K $7.43 M $7.07 M $4.32 M $3.07 M $2.77 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $15.37 M $16.38 M $14.91 M $7.73 M $3.60 M $34.09 M $42.47 M $28.61 M $13.15 M $6.85 M
Cost And Expenses -$15.37 M $16.38 M $14.91 M $7.73 M $3.60 M $34.95 M $43.33 M $29.44 M $13.85 M $7.60 M
Interest Income $0.00 $0.00 $588.11 K $17.72 K $15.11 K $330.00 K $852.00 K $286.00 K $176.00 K $44.79 K
Interest Expense $0.00 $0.00 $588.11 K $0.00 $0.00 $15.00 K $23.00 K $17.00 K $16.00 K $0.00
Depreciation & Amortization $735.00 $1.28 K $1.78 K $1.40 K $852.00 $854.00 K $859.00 K $829.00 K $701.00 K $745.90 K
EBITDA -$15.02 M -$16.38 M -$14.91 M -$7.73 M -$3.60 M -$46.09 M -$42.56 M -$28.61 M -$13.15 M -$6.43 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $343.72 K $955.00 K $588.11 K $17.72 K $15.11 K -$12.02 M -$112.00 K $559.00 K $484.00 K $423.40 K
Income Before Tax -$15.02 M -$15.42 M -$14.32 M -$7.71 M -$3.58 M -$46.96 M -$43.44 M -$28.88 M -$13.36 M -$7.18 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$588.11 K -$17.72 K -$15.11 K $638.00 K $103.00 K $29.00 K $0.00 -$4.00
Net Income -$15.02 M -$15.42 M -$13.73 M -$7.69 M -$3.57 M -$47.60 M -$43.54 M -$28.91 M -$13.36 M -$7.18 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -1.61 -1.84 -1.66 -1.88 -0.66 -112.74 -111.67 -130.96 -93.38 -73.7
EPS Diluted -1.61 -1.84 -1.66 -1.88 -0.66 -112.74 -111.67 -130.96 -93.38 -73.7
Weighted Average Shares Out $9.36 M $8.40 M $8.26 M $4.09 M $5.41 M $422.20 K $389.91 K $220.75 K $143.10 K $97.39 K
Weighted Average Shares Out Diluted $9.36 M $8.40 M $8.26 M $4.09 M $5.41 M $422.20 K $389.91 K $220.75 K $143.10 K $97.39 K
Link